• Innovative biotechnology company

  focused on the discovery and the development of biopharmaceuticals to provide innovative therapies in hepatology and oncology disorders

  Mission & Strategy 

• Founded in 2006

  by two hepato-gastro-enterologists, with the idea of bringing new therapeutic perspective for the treatment of liver diseases

  History & Funding 

• Strong collaborative research

  with its historical partner Inserm-Paris XI unit 785.

  Collaborative research 

1 2 3